BioSpace News Archive

Deals

Beckman Coulter Acquires Artificial Intelligence Company Providing Evidence-Based Clinical Decision Support for Emergency Departments

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, announced it acquired StoCastic, LLC., a leading artificial intelligence company that provides evidence-based decision support for hospital emergency departments.

October 11, 2022
·
4 min read
Biotech Bay

U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Gilead’s Trodelvy® for Pre-Treated HR+/HER2- Metastatic Breast Cancer

U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Gilead’s Trodelvy ® for Pre-Treated HR+/HER2- Metastatic Breast Cancer.

October 11, 2022
·
16 min read
BioMidwest

6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe

Surmodics, Inc. (NASDAQ:SRDX) today announced that 6-month data from its SWING first-in-human (FIH) study of the company’s Sundance™ Sirolimus drug-coated balloon (DCB) was shared at the Amputation Prevention Symposium (AMP) in Lugano, Switzerland.

October 11, 2022
·
4 min read
Business

HeartBeam Names Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer

HeartBeam, Inc. today announced the appointment of Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer.

October 11, 2022
·
4 min read
Biotech Bay

Tenon Medical Accelerates Commercial Scale with Own Infrastructure to Support Top Line Growth, Terminates National Distribution Agreement for Company’s Catamaran(TM) SI Joint Fusion System

Tenon Medical, Inc. today announced the termination of its national distribution agreement with distribution partner, SpineSource, for the Company’s Catamaran™ SI Joint Fusion System.

October 11, 2022
·
4 min read
BioForest

Cocrystal Pharma Selects CDI-988 for Clinical Development as an Oral Treatment for COVID-19

Cocrystal Pharma, Inc. (Nasdaq: COCP) announces the selection of its novel, broad-spectrum antiviral drug candidate CDI-988 for clinical development as an oral treatment for SARS-CoV-2, the virus that causes COVID-19.

October 11, 2022
·
4 min read
Lipocine to Present at H.C. Wainwright 6th Annual NASH Investor Conference

Lipocine Inc announced today that it will present at the H.C. Wainwright 6th Annual NASH Investor Conference to be held virtually on October 17.

October 11, 2022
·
3 min read
Deals

Momentis Announces HCA Florida Northwest Hospital Acquires Anovo™ Surgical System

Momentis Surgical™ Ltd, a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that HCA Florida Northwest Hospital has acquired the Anovo™ Surgical System for use in transvaginal benign gynecological procedures including hysterectomies.

October 11, 2022
·
4 min read
Business

Incyte to Report Third Quarter 2022 Financial Results

Incyte announced that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, November 1, 2022.

October 11, 2022
·
1 min read
Genetown

Vertex Advances Program Targeting Alpha-1 Antitrypsin Deficiency

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the advancement of its investigational program targeting alpha-1 antitrypsin deficiency (AATD), a rare, genetic disease characterized by a protein folding defect that can lead to liver and lung disease.

October 11, 2022
·
7 min read